NCT07439172 Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. Status NOT_YET_RECRUITING Phase PHASE2
NCT07346144 Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma Status RECRUITING Phase PHASE1/PHASE2
NCT07331064 Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor Status NOT_YET_RECRUITING Phase PHASE1
NCT07210632 Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) Status RECRUITING Phase EARLY_PHASE1
NCT07061626 Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma Status NOT_YET_RECRUITING Phase PHASE1
NCT07017816 A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies. Status RECRUITING Phase EARLY_PHASE1
NCT06740097 Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery Status RECRUITING Phase NA
NCT06607692 Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). Status RECRUITING Phase PHASE1/PHASE2
NCT00918281 Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection Status COMPLETED Phase PHASE2
NCT00743353 Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 Status COMPLETED Phase EARLY_PHASE1
NCT00302159 Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors Status COMPLETED Phase PHASE2